Suppr超能文献

一些新型喹诺酮基-3'-青霉素和4'-头孢菌素衍生物的合成及其抗菌活性

Synthesis and antimicrobial activities of some new quinolonyl-3'-penicillin and 4'-cephalosporin derivatives.

作者信息

Bhanot S K, Chatterjee N R, Naik S R

机构信息

Research & Development Centre, Hindustan Antibiotics Limited, Pimpri, Pune, India.

出版信息

Arzneimittelforschung. 1994 May;44(5):663-7.

PMID:8024644
Abstract

A number of quinolonyl-3'-penicillin and 4'-cephalosporin derivatives have been synthesised incorporating imino group of fluoroquinolone antibacterials, viz. norfloxacin and ciprofloxacin, into carboxylic acid group of a number of semisynthetic penicillins and cephalosporins via their mixed anhydride, thereby forming an amide linkage at 3 and 4 position of the penicillin and cephalosporin component, respectively. The structure of these compounds was confirmed by spectral data and elemental analysis. The antibacterial activity of the compounds in vitro were investigated against some bacterial strains by agar plate diffusion method. While most of the compounds showed broad spectrum activity, compounds VIa and VIb exhibited higher activity against Ps. aeruginosa, K. pneumoniae and S. aureus than that of norfloxacin suggesting a dual mode of action. No untoward reaction was observed during toxicity studies of the compounds upto 1 g/kg body weight by oral route in albino mice.

摘要

已合成了多种喹诺酮基-3'-青霉素和4'-头孢菌素衍生物,即将氟喹诺酮类抗菌剂(即诺氟沙星和环丙沙星)的亚氨基通过其混合酸酐引入到多种半合成青霉素和头孢菌素的羧酸基团中,从而分别在青霉素和头孢菌素组分的3位和4位形成酰胺键。这些化合物的结构通过光谱数据和元素分析得以确证。采用琼脂平板扩散法对这些化合物针对某些细菌菌株的体外抗菌活性进行了研究。虽然大多数化合物表现出广谱活性,但化合物VIa和VIb对铜绿假单胞菌、肺炎克雷伯菌和金黄色葡萄球菌的活性高于诺氟沙星,提示其具有双重作用模式。在对白化病小鼠进行口服给药、剂量高达1 g/kg体重的化合物毒性研究期间,未观察到不良反 应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验